GoHealth (NASDAQ:GOCO – Get Rating) had its price objective boosted by Credit Suisse Group from $7.00 to $8.50 in a report published on Tuesday, Benzinga reports. The firm currently has an underperform rating on the stock. Several other equities research analysts have also recently weighed in on the stock. Royal Bank of Canada lowered their […]